56671-1 |
Alanine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Alanine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56671-1 |
|
|
|
|
Both |
|
|
|
0 |
Alanine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Ala; Alpha alanine; Chemistry; CR; Crea; Creat; L-alanine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56672-9 |
Arginine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Arginine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56672-9 |
|
|
|
|
Both |
|
|
|
0 |
Arginine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Arg; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56673-7 |
Beta aminoisobutyrate/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Beta aminoisobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56673-7 |
|
|
|
|
Both |
|
|
|
0 |
B-AIB/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; 3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56674-5 |
Beta alanine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Beta alanine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56674-5 |
|
|
|
|
Both |
|
|
|
0 |
B-Alanine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Ala; Alpha alanine; B; Bala; B-Ala; B-Alanine; Chemistry; CR; Crea; Creat; L-alanine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56675-2 |
Carnosine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Carnosine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56675-2 |
|
|
|
|
Both |
|
|
|
0 |
Carnosine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Car; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56676-0 |
Citrulline/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Citrulline/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56676-0 |
|
|
|
|
Both |
|
|
|
0 |
Citrulline/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CIT; Citr; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56677-8 |
Cystine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Cystine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56677-8 |
|
|
|
|
Both |
|
|
|
0 |
Cystine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Cys-Cys; Dicysteine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.73 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56678-6 |
Ethanolamine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Ethanolamine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56678-6 |
|
|
|
|
Both |
|
|
|
0 |
Ethanolamine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; EA; Etn; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56679-4 |
Gamma aminobutyrate/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Gamma aminobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56679-4 |
|
|
|
|
Both |
|
|
|
0 |
GABA/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Chemistry; CR; Crea; Creat; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Piperidic acid; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
5668-9 |
Isopropanol |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Isopropanol [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
5668-9 |
|
|
|
|
Both |
|
|
|
0 |
Isopropanol SerPl Ql |
|
|
|
|
|
2-propanol; c615; DRUG/TOXICOLOGY; Drugs; Isopropyl alcohol; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
56680-2 |
Glutamine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Glutamine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56680-2 |
|
|
|
|
Both |
|
|
|
0 |
Glutamine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Gln; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56681-0 |
Glycine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Glycine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56681-0 |
|
|
|
|
Both |
|
|
|
0 |
Glycine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Gly; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56682-8 |
Homocystine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Homocystine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56682-8 |
|
|
|
|
Both |
|
|
|
0 |
(Hcys)2/Creat 24h Ur-Rto |
|
|
|
N |
|
(Hcys)2; 1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Homocyst(e)ine; Homocystin; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56683-6 |
Histidine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Histidine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56683-6 |
|
|
|
|
Both |
|
|
|
0 |
Histidine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Formiminoglutamic Acidemia; His; Histidinemia; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56684-4 |
Hydroxylysine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Hydroxylysine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56684-4 |
|
|
|
|
Both |
|
|
|
0 |
OH-Lysine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Hydroxy lysine; Hydroxyl; OH-Lysine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56685-1 |
Hydroxyproline.free |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Hydroxyproline Free [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
56685-1 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline Free SerPl-sCnc |
|
|
|
N |
|
Chemistry; FR; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Non-protein bound; Ohpro; OH-Proline; OH-Proline Free; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
56686-9 |
Hydroxyproline.free/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Hydroxyproline Free/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56686-9 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline Free/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; FR; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Non-protein bound; Ohpro; OH-Proline; OH-Proline Free; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
56687-7 |
Pancreatic islet cell Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56687-7 |
|
IF |
|
|
Both |
|
|
|
0 |
Panc Islet Cell IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; ICA; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Panc Islet Cell; Pancr; Pancreatc; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UniversalLabOrders |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
56688-5 |
IgD |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
IgD [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
CHEM |
|
56688-5 |
|
|
|
|
Both |
|
|
|
0 |
IgD Ser-aCnc |
|
|
|
N |
|
Arbitrary concentration; Chemistry; Immune globulin D; Immunoglobulin D; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.7 |
2.29 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
56689-3 |
Isoleucine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Isoleucine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56689-3 |
|
|
|
|
Both |
|
|
|
0 |
Isoleucine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Ile; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
5669-7 |
Isopropanol |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Isopropanol [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
5669-7 |
|
|
|
|
Both |
|
|
|
0 |
Isopropanol SerPl-mCnc |
|
|
|
Y |
|
2-propanol; c615; DRUG/TOXICOLOGY; Drugs; Isopropyl alcohol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
56690-1 |
Insulin^16H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Insulin [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHAL |
|
56690-1 |
|
|
|
|
Observation |
|
|
|
0 |
Insulin 16h p chal SerPl-mCnc |
|
|
|
N |
|
16h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente |
2.7 |
2.29 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
56691-9 |
Insulin^20H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Insulin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHAL |
|
56691-9 |
|
|
|
|
Observation |
|
|
|
0 |
Insulin 20H p chal SerPl-mCnc |
|
|
|
N |
|
20H p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente |
2.4 |
2.29 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
56692-7 |
Insulin^1D post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Insulin [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHAL |
|
56692-7 |
|
|
|
|
Observation |
|
|
|
0 |
Insulin 1D p chal SerPl-mCnc |
|
|
|
N |
|
1D p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente |
2.4 |
2.29 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
56693-5 |
SCL-70 extractable nuclear Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56693-5 |
|
IB |
|
|
Both |
|
|
|
0 |
ENA Scl70 Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; Blt; DNA-Topoisomerase I; ENA; ENA Scl70; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Scleroderma; Scleroderma ab; Screen; Serology; Serum; SR; Topo I; Topoisomerase I; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.29 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |